DE69535366D1 - Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt - Google Patents

Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt

Info

Publication number
DE69535366D1
DE69535366D1 DE69535366T DE69535366T DE69535366D1 DE 69535366 D1 DE69535366 D1 DE 69535366D1 DE 69535366 T DE69535366 T DE 69535366T DE 69535366 T DE69535366 T DE 69535366T DE 69535366 D1 DE69535366 D1 DE 69535366D1
Authority
DE
Germany
Prior art keywords
hiv
treating
composition
reverse transcriptase
transcriptase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535366T
Other languages
English (en)
Other versions
DE69535366T2 (de
Inventor
Maria Balzarini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REGA INST
Original Assignee
REGA INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REGA INST filed Critical REGA INST
Application granted granted Critical
Publication of DE69535366D1 publication Critical patent/DE69535366D1/de
Publication of DE69535366T2 publication Critical patent/DE69535366T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE69535366T 1994-11-30 1995-11-29 Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt Expired - Lifetime DE69535366T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/346,721 US5968910A (en) 1994-11-30 1994-11-30 Compositions containing two or three inhibitors of different HIV reverse transcriptases
US346721 1994-11-30
PCT/EP1995/004704 WO1996016675A2 (en) 1994-11-30 1995-11-29 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
DE69535366D1 true DE69535366D1 (de) 2007-02-22
DE69535366T2 DE69535366T2 (de) 2007-10-11

Family

ID=23360750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535366T Expired - Lifetime DE69535366T2 (de) 1994-11-30 1995-11-29 Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt

Country Status (16)

Country Link
US (1) US5968910A (de)
EP (1) EP0794793B1 (de)
JP (1) JP3655636B2 (de)
KR (1) KR100403545B1 (de)
CN (1) CN1104909C (de)
AU (1) AU717025B2 (de)
BR (1) BR9509925A (de)
CA (1) CA2204652C (de)
DE (1) DE69535366T2 (de)
HU (1) HU223548B1 (de)
IL (1) IL115944A (de)
MX (1) MX9704024A (de)
NZ (1) NZ297006A (de)
RU (1) RU2227750C2 (de)
WO (1) WO1996016675A2 (de)
ZA (1) ZA9510108B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696151A (en) * 1995-11-30 1997-12-09 Uniroyal Chemical Company, Inc. Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants
AU9016998A (en) * 1997-08-08 1999-03-01 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
DK1045897T3 (da) 1998-01-23 2002-05-13 Newbiotics Inc Enzymatisk katalyserede, terapeutiske midler
WO2001007088A2 (en) 1999-07-22 2001-02-01 Newbiotics, Inc. Methods for treating therapy-resistant tumors
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
WO2001021160A2 (en) * 1999-09-23 2001-03-29 Axxima Pharmaceuticals Aktiengesellschaft Carboxymide and aniline derivatives as selective inhibitors of pathogens
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
CN101108178B (zh) * 2006-07-20 2010-09-15 复旦大学 一种亲环素a抑制剂在制备抗艾滋病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268389A (en) * 1989-10-16 1993-12-07 Uniroyal Chemical Company, Inc. Thiocarboxylate ester compounds compositions containing the same
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
ES2087962T3 (es) * 1991-09-04 1996-08-01 Stichting Rega V Z W Derivados nucleosidos sustituidos, metodos para su preparacion y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
DE69535366T2 (de) 2007-10-11
KR987000088A (ko) 1998-03-30
RU2227750C2 (ru) 2004-04-27
BR9509925A (pt) 1997-09-30
NZ297006A (en) 2001-03-30
EP0794793B1 (de) 2007-01-10
WO1996016675A2 (en) 1996-06-06
AU717025B2 (en) 2000-03-16
JPH10500996A (ja) 1998-01-27
ZA9510108B (en) 1996-06-06
IL115944A0 (en) 1996-05-14
CN1104909C (zh) 2003-04-09
HU223548B1 (hu) 2004-09-28
IL115944A (en) 2001-10-31
MX9704024A (es) 1998-02-28
CN1167442A (zh) 1997-12-10
HUT77573A (hu) 1998-06-29
US5968910A (en) 1999-10-19
WO1996016675A3 (en) 1996-08-29
CA2204652C (en) 2009-04-07
AU4176996A (en) 1996-06-19
KR100403545B1 (ko) 2004-05-27
EP0794793A1 (de) 1997-09-17
JP3655636B2 (ja) 2005-06-02
CA2204652A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
ATE318138T1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69711034T2 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69018457T2 (de) Gegenstände zur behandlung von periodontitis und knochendefekten.
DE69805973T2 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE3884200D1 (de) Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.
ATE312079T1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE69527140T2 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE69905616D1 (de) Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
SE9604348D0 (sv) Användning av hydroxyguanidiner
DE69535366D1 (de) Zusammensetzung zur behandlung und vorbeugung von hiv-1 infektionen, welche mindestens zwei verschiedene hiv-1 reverse transcriptase inhibitoren enthalt
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
ATE278441T1 (de) Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind
DE69033413D1 (de) Mittel zur Behandlung von Metalloberflächen
DE69900168T2 (de) Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DE3765137D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
DE69002558D1 (de) Zusammensetzungen und methoden zur verhinderung von inkrustierungen.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE69014501D1 (de) Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück.
DE59910146D1 (de) Topisch anwendbares arzneimittel zur behandlung von virusinfektionen
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN